Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;4(1):18-41.
doi: 10.3390/antibiotics4010018.

Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria

Affiliations

Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria

Victor I Band et al. Antibiotics (Basel). 2015 Mar.

Abstract

Cationic antimicrobial peptides (CAMPs) are important innate immune defenses that inhibit colonization by pathogens and contribute to clearance of infections. Gram-negative bacterial pathogens are a major target, yet many of them have evolved mechanisms to resist these antimicrobials. These resistance mechanisms can be critical contributors to bacterial virulence and are often crucial for survival within the host. Here, we summarize methods used by Gram-negative bacteria to resist CAMPs. Understanding these mechanisms may lead to new therapeutic strategies against pathogens with extensive CAMP resistance.

Keywords: AMP; CAMP; Gram-negative; antibiotic resistance; antimicrobial peptide.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bacterial surface modifications that enhance cationic antimicrobial peptide (CAMP) resistance. Gram-negative bacterial cell wall structure (A), with magnification of (B) capsule, (C) lipopolysaccharide, and (D) outer and plasma membranes. Lipopolysaccharide (LPS) structure varies greatly across species; depicted is a representative E. coli LPS structure, with modifications from various other species.

References

    1. UNMC Department of Pathology and Microbiology The antimicrobial peptide database. 2014. [(accessed on 2 July 2014)]. Available online: http://aps.unmc.edu/AP/main.php.
    1. Nakatsuji T., Gallo R.L. Antimicrobial peptides: Old molecules with new ideas. J. Invest. Dermatol. 2012;132:887–895. doi: 10.1038/jid.2011.387. - DOI - PMC - PubMed
    1. Wimley W.C. Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem. Biol. 2010;5:905–917. doi: 10.1021/cb1001558. - DOI - PMC - PubMed
    1. Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 2006;8:11–26. - PubMed
    1. Zavascki A.P., Goldani L.Z., Li J., Nation R.L. Polymyxin b for the treatment of multidrug-resistant pathogens: A critical review. J. Antimicrob. Chemother. 2007;60:1206–1215. doi: 10.1093/jac/dkm357. - DOI - PubMed

LinkOut - more resources